Home/Filings/4/0001193805-22-001718
4//SEC Filing

Markels John 4

Accession 0001193805-22-001718

CIK 0001768224other

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 4:10 PM ET

Size

7.9 KB

Accession

0001193805-22-001718

Insider Transaction Report

Form 4
Period: 2022-12-08
Markels John
Director
Transactions
  • Award

    Stock option (right to buy)

    2022-12-08+6,9866,986 total
    Exercise: $18.04Exp: 2032-12-08Common Stock (6,986 underlying)
  • Award

    Stock option (right to buy)

    2022-12-08+20,00020,000 total
    Exercise: $18.04Exp: 2032-12-08Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]Shares underlying the option vest monthly over a two year period from the date of grant. This represents the initial grant to the Reporting Person as a member of the Board of Directors (the "Board").
  • [F2]Shares underlying the option vest monthly over a one year period from the date of grant. This represents the annual grant to the Reporting Person as a member of the Board, prorated based on the date the Reporting Person was appointed to the Board, representing an estimated six months of service.

Issuer

Arcturus Therapeutics Holdings Inc.

CIK 0001768224

Entity typeother

Related Parties

1
  • filerCIK 0001803424

Filing Metadata

Form type
4
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:10 PM ET
Size
7.9 KB